Editas Medicine Inc (EDIT)
5.208
+0.04
(+0.73%)
USD |
NASDAQ |
May 31, 16:00
5.20
-0.01
(-0.14%)
After-Hours: 20:00
Editas Medicine Market Cap: 428.25M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 428.25M |
| May 30, 2024 | 425.17M |
| May 29, 2024 | 419.41M |
| May 28, 2024 | 437.51M |
| May 24, 2024 | 463.00M |
| May 23, 2024 | 479.45M |
| May 22, 2024 | 495.07M |
| May 21, 2024 | 453.13M |
| May 20, 2024 | 453.95M |
| May 17, 2024 | 462.18M |
| May 16, 2024 | 484.38M |
| May 15, 2024 | 493.43M |
| May 14, 2024 | 467.11M |
| May 13, 2024 | 469.58M |
| May 10, 2024 | 437.51M |
| May 09, 2024 | 457.24M |
| May 08, 2024 | 414.07M |
| May 07, 2024 | 467.11M |
| May 06, 2024 | 465.47M |
| May 03, 2024 | 466.29M |
| May 02, 2024 | 462.16M |
| May 01, 2024 | 449.82M |
| April 30, 2024 | 428.44M |
| April 29, 2024 | 441.60M |
| April 26, 2024 | 437.49M |
| Date | Value |
|---|---|
| April 25, 2024 | 429.27M |
| April 24, 2024 | 439.96M |
| April 23, 2024 | 449.00M |
| April 22, 2024 | 460.51M |
| April 19, 2024 | 451.47M |
| April 18, 2024 | 456.40M |
| April 17, 2024 | 461.34M |
| April 16, 2024 | 481.07M |
| April 15, 2024 | 499.99M |
| April 12, 2024 | 510.68M |
| April 11, 2024 | 541.10M |
| April 10, 2024 | 545.22M |
| April 09, 2024 | 576.47M |
| April 08, 2024 | 552.62M |
| April 05, 2024 | 552.62M |
| April 04, 2024 | 560.02M |
| April 03, 2024 | 564.13M |
| April 02, 2024 | 564.95M |
| April 01, 2024 | 598.67M |
| March 28, 2024 | 607.06M |
| March 27, 2024 | 608.70M |
| March 26, 2024 | 590.70M |
| March 25, 2024 | 602.15M |
| March 22, 2024 | 611.15M |
| March 21, 2024 | 640.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
414.07M
Minimum
May 08 2024
5.667B
Maximum
Jan 08 2021
1.515B
Average
1.180B
Median
Jul 08 2019
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 117.50B |
| Bristol-Myers Squibb Co | 83.29B |
| Regeneron Pharmaceuticals Inc | 108.05B |
| Cabaletta Bio Inc | 490.97M |
| Oragenics Inc | 9.051M |
Market Cap Related Metrics
| PS Ratio | 5.941 |
| Price to Book Value | 1.455 |
| Price | 5.208 |
| Earnings Yield | -40.33% |